Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System

Pyrazinamide (PZA) is a key antituberculosis drug, yet no rapid susceptibility test is commercially available. PZA drug susceptibility testing (DST) was performed directly on sputum samples from 327 patients and compared with the indirect method by using the Bactec MGIT 960 system in the context of...

Descripción completa

Detalles Bibliográficos
Autores principales: Demers, Anne-Marie, Venter, Amour, Friedrich, Sven O., Rojas-Ponce, Gabriel, Mapamba, Daniel, Jugheli, Levan, Sasamalo, Mohammed, Almeida, Deepak, Dorasamy, Afton, Jentsch, Ute, Gibson, Mara, Everitt, Daniel, Eisenach, Kathleen D., Diacon, Andreas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Mycobacteriology and Aerobic Actinomycetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844746/
https://www.ncbi.nlm.nih.gov/pubmed/26912751
http://dx.doi.org/10.1128/JCM.03162-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844746/
https://www.ncbi.nlm.nih.gov/pubmed/26912751
http://dx.doi.org/10.1128/JCM.03162-15

Ejemplares similares